Marilene Rodrigues Chang

Prof. Dr. Marilene Rodrigues Chang

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2016 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
ASAna C. P. Souto
Ana C. P. Souto
LBLucas X. Bonfietti
Lucas X. Bonfietti
Kennio Ferreira-PaimKennio Ferreira-Paim
Kennio Ferreira-Paim
LTLuciana Trilles
Luciana Trilles
MMMarilena Martins
Marilena Martins
Wieland MeyerWieland Meyer
Wieland Meyer
Cryptococcus neoformans and Cryptococcus gattii are responsible globally for almost one million cryptococcosis cases yearly, mostly in immunocompromised patients, such as those living with HIV. Infections due to C. gattii have mainly been described in tropical and subtropical regions, but its adaptation to temperate regions was crucial in the species evolution and highlighted the importance of this pathogenic yeast in the context of disease. Cryptococcus gattii molecular type VGII has come to the forefront in connection with an on-going emergence in the Pacific North West of North America. Taking into account that previous work pointed towards South America as an origin of this species, the present work aimed to assess the genetic diversity within the Brazilian C. gattii VGII population in order to gain new insights into its origin and global dispersal from the South American continent using the ISHAM consensus MLST typing scheme. Our results corroborate the finding that the Brazilian C. gattii VGII population is highly diverse. The diversity is likely due to recombination generated from sexual reproduction, as evidenced by the presence of both mating types in clinical and environmental samples. The data presented herein strongly supports the emergence of highly virulent strains from ancestors in the Northern regions of Brazil, Amazonia and the Northeast. Numerous genotypes represent a link between Brazil and other parts of the world reinforcing South America as the most likely origin of the C. gattii VGII subtypes and their subsequent global spread, including their dispersal into North America, where they caused a major emergence. Cryptococcus neoformans and Cryptococcus gattii are fungal agents responsible globally for almost one million cryptococcosis cases yearly, mostly in immunocompromised patients, such as those living with HIV. Cryptococcosis is a life-threatening mycosis, frequently causing meningoencephalitis. Infections due to C. gattii were originally described in tropical and subtropical regions, but its adaptation to temperate regions was highlighted by the emergence in the Pacific North West of North America by C. gattii molecular type VGII. The present work aimed to assess the genetic diversity within the Brazilian C. gattii VGII population to gain new insights into its origin and global dispersal from the South American continent using the ISHAM MLST consensus typing scheme. Our results corroborate that the Brazilian C. gattii VGII population is highly diverse, and strongly supports the emergence of highly virulent strains from ancestors in the Northern regions of Brazil. Numerous genotypes represent a link between Brazil and other parts of the world, and the isolates from the transitional ecological area in Northeast Brazil are the most likely ancestor lineages, translocating from caatinga/cerrado by adapting progressively throughout Amazonia in South America, and spread to the North American Pacific Northwest region and other parts of the world on multiple occasions.

20 April 2020 in Fungal Genetics and Biology
Verified
Journal Article
Closed access
MTMarcus de Melo Teixeira
Marcus de Melo Teixeira
MCMaria Emilia Cattana
Maria Emilia Cattana
DMDaniel R. Matute
Daniel R. Matute
JMJosé F. Muñoz
José F. Muñoz
AAAlicia Arechavala
Alicia Arechavala
GGGustavo Gustavo Giusiano
Gustavo Gustavo Giusiano

16 December 2019 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
OTOzildéia S. Trefzger
Ozildéia S. Trefzger
NBNatália V. Barbosa
Natália V. Barbosa
RSRenata L. Scapolatempo
Renata L. Scapolatempo
ANAmarith R. das Neves
Amarith R. das Neves
MOMaria L. F. S. Ortale
Maria L. F. S. Ortale
ABAdriano C. M. Baroni
Adriano C. M. Baroni

1 April 2008 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
ALAndrea De Siqueira Campos Lindenberg
Andrea De Siqueira Campos Lindenberg
MCMarilene Rodrigues Chang
Marilene Rodrigues Chang
APAnamaria Mello Miranda Paniago
Anamaria Mello Miranda Paniago
MLMárcia Dos Santos Lazéra
Márcia Dos Santos Lazéra
PMPaula Maria Frank Moncada
Paula Maria Frank Moncada
BWBodo Wanke
Bodo Wanke
To identify the clinical and epidemiological profile of cryptococcosis diagnosed at the University Hospital of the Federal University of Mato Grosso do Sul, Brazil, medical records of 123 patients admitted from January 1995 to December 2005 were analyzed. One hundred and four cases (84.5%) had HIV infection, six (4.9%) had other predisposing conditions and 13 (10.6%) were immunocompetent. Male patients predominated (68.3%) and their age ranged from 19 to 69 years (mean: 35.9). Most patients (73.2%) were born and lived lifelong in the state of Mato Grosso do Sul. Involvement of the central nervous system occurred in 103 patients (83.7%) and headache and vomiting were the most frequent symptoms. In 77 cases it was possible to identify the Cryptococcus species: 69 (89.6%) C. neoformans and eight (10.4%) C. gattii. Amphotericin B was the drug of choice for treatment (106/123), followed by fluconazole in 60% of cases. The overall lethality rate was 49.6%, being 51% among the HIV infected patients and 41.2% among the non-HIV infected (p > 0.05). Although cryptococcosis exhibited in our region a similar behavior to that described in the literature, the detection of an important rate of immunocompetent individuals and five C. gattii cryptococcosis in HIV-infected patients is noteworthy.

29 September 2020 in Molecules
Verified
Journal Article
Open access
PDF file
CCCynthia S. A. Caires
Cynthia S. A. Caires
CSCicera M. Silva
Cicera M. Silva
ALAlessandra Ramos Lima
Alessandra Ramos Lima
LALurian M. Alves
Lurian M. Alves
TLThalita H. N. Lima
Thalita H. N. Lima
Anderson R. L. CairesAnderson R. L. Caires
Anderson R. L. Caires
This study evaluates the photosensitizing effectiveness of sodium copper chlorophyllin, a natural green colorant commonly used as a food additive (E-141ii), to inactivate methicillin-sensitive and methicillin-resistant Staphylococcus aureus under red-light illumination. Antimicrobial photodynamic inactivation (aPDI) was tested on a methicillin-sensitive reference strain (ATCC 25923) and a methicillin-resistant Staphylococcus aureus strain (GenBank accession number Mh087437) isolated from a clinical sample. The photoinactivation efficacy was investigated by exposing the bacterial strains to different E-141ii concentrations (0.0, 1.0, 2.5, 5.0, 10.0, and 20.0 µM) and to red light (625 nm) at 30 J cm−2. The results showed that E-141ii itself did not prevent bacterial growth for all tested concentrations when cultures were placed in the dark. By contrast, E-141ii photoinactivated both methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) under red-light illumination. However, different dose responses were observed for MSSA and MRSA. Whilst the MSSA growth was inhibited to the detection limit of the method with E-141ii at 2.5 µM, >10 µM concentrations were required to inhibit the growth of MRSA. The data also suggest that E-141ii can produce reactive oxygen species (ROS) via Type I reaction by electron transfer from its first excited singlet state to oxygen molecules. Our findings demonstrate that the tested food colorant has great potential to be used in aPDI of MRSA.

1 June 2015 in Brazilian Journal of Microbiology
Verified
Journal Article
Open access
PDF file
CBCamila Arguelo Biberg
Camila Arguelo Biberg
ARAna Claudia Souza Rodrigues
Ana Claudia Souza Rodrigues
SCSidiane Ferreira Do Carmo
Sidiane Ferreira Do Carmo
CCClaudia Elizabeth Volpe Chaves
Claudia Elizabeth Volpe Chaves
AGAna Cristina Gales
Ana Cristina Gales
MCMarilene Rodrigues Chang
Marilene Rodrigues Chang
The emergence of β-lactamase-producing Enterobacteriaceae in the last few decades has become major challenge faced by hospitals. In this study, isolates of Klebsiella pneumoniae carbapenemase-2 (KPC-2)-producing K. pneumoniae from a tertiary hospital in Mato Grosso do Sul, Brazil, were characterized. Bacterial identification was performed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF; Bruker Daltonics, Germany) mass spectrometry. The minimum inhibitory concentrations of carbapenems were determined using the agar dilution method as recommended by the Clinical Laboratory Standards Institute guidelines. Carbapenemase production was detected using the modified Hodge test (MHT) and polymerase chain reaction (PCR), followed by DNA sequencing. Of 360 (12.2%) K. pneumoniae isolates obtained between May 2009 and May 2010, 44 (12.2%) were carbapenem nonsusceptible. Of these 44 isolates, thirty-six K. pneumoniae isolates that were positive by MHT and PCR carried the blaKPC-2 gene. Thus, KPC-2producing Klebsiella pneumoniae has been present in a Brazilian hospital located in the Midwest region since at least 2009.